Citations

Clear

750 citation(s) found for "Lowe, Val".

Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype
Buciuc, Marina , Whitwell, Jennifer L. , Kasanuki, Koji , Graff‐Radford, Jonathan , Lowe, Val J. , Graff‐Radford, Neill R. , Rush, Beth , Franczak, Malgorzata, Flanagan, Margaret E. , Rademakers, Rosa , Ross, Owen A. , Parisi, Joseph E., Reichard, R. Ross , Bigio, Eileen H. , Josephs, Keith A. , Strand, Edythe A. , Baker, Matthew C, Ross, Owen A , Dickson, Dennis W , Josephs, Keith A , Buciuc, Marina , Machulda, Mary M. , Duffy, Joseph R. , Baker, Matthew , Ghetti, Bernardino , Raghunathan, Aditya , Dickson, Dennis W. , Flanagan, Margaret E

Mayo Clinic

Annals of Neurology | December 4, 2020 | Volume: 89 | Issue: 3 | Pages: 520-533

10.1002/ana.25979 | PMID 33274526 Get It

ObjectiveThe objective of this study was to describe clinical features, [18F]‐fluorodeoxyglucose (FDG)‐positron emission tomography (PET) metabolism and digital pathology in patients with logopenic progressive aphasia (LPA) and pathologic diagnosis of diffuse Lewy body disease (DLBD) and compare to patients with LPA with other pathologies, as well as patients with classical features of probable dementia with Lewy bodies (pDLB).MethodsThis is a clinicopathologic case‐control study of 45 patients, including 20 prospectively recruited patients with LPA among whom 6 were diagnosed with LPA‐DLBD. We analyzed clinical features and compared FDG‐PET metabolism in LPA‐DLBD to an independent group of patients with clinical pDLB and regional α‐synuclein burden on digital pathology to a second independent group of autopsied patients with DLBD pathology and antemortem pDLB (DLB‐DLBD).ResultsAll patients with LPA‐DLBD were men. Neurological, speech, and neuropsychological characteristics were similar across LPA‐DLBD, LPA‐Alzheimer's disease (LPA‐AD), and LPA‐frontotemporal lobar degeneration (LPA‐FTLD). Genetic screening of AD, DLBD, and FTLD linked genes were negative with the exception of APOE ε4 allele present in 83% of LPA‐DLBD patients. Seventy‐five percent of the patients with LPA‐DLBD showed a parietal‐dominant pattern of hy pometabolism; LPA‐FTLD – temporal‐dominant pattern, whereas LPA‐AD showed heterogeneous patterns of hypometabolism. LPA‐DLBD had more asymmetrical hypometabolism affecting frontal lobes, with relatively spared occipital lobe in the nondominantly affected hemisphere, compared to pDLB. LPA‐DLBD had minimal atrophy on gross brain examination, higher cortical Lewy body counts, and higher α‐synuclein burden in the middle frontal and inferior parietal cortices compared to DLB‐DLBD.InterpretationWhereas AD is the most frequent underlying pathology of LPA, DLBD can also be present and may contribute to the LPA phenotype possibly due to α‐synuclein‐associated functional impairment of the dominant parietal lobe. ANN NEUROL 2021;89:520–533
FDG‐PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG‐PET/CT cN0
Stack, Brendan C. , Duan, Fenghai , Subramaniam, Rathan M. , Romanoff, Justin , Sicks, JoRean D. , Bartel, Twyla B. , Chen, Chien , Lowe, Val J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | November 24, 2020 | Volume: 164 | Issue: 6 | Pages: 1230-1239

10.1177/0194599820969104 | PMID 33231504 Get It

ObjectiveFDG‐PET/CT (fluorodeoxyglucose–positron emission tomography/computed tomography) is effective to assess for occult neck nodal disease. We report risks and patterns of nodal disease based on primary site and nodal level from data on the dissected cN0 per the results from ACRIN 6685.Study DesignProspective nonrandomized enrollment included participants with first‐time head and neck squamous cell carcinoma and at least 1 cN0 neck side to be dissected.SettingTwenty‐four ACRIN‐certified centers internationally (American College of Radiology Imaging Network).MethodsA total of 287 participants were enrolled. Preoperative FDG‐PET/CT findings were centrally reviewed and compared with pathology. Incidence, relative risk, pattern of lymph node involvement, and impact upon neck dissection were reported.ResultsAn overall 983 nodal levels were dissected (n = 261 necks, n = 203 participants). The highest percentages of ipsilateral positive nodes by primary location and nodal level were oral cavity (level I, 17/110, 15.5%), pharynx (level II, 6/30, 20.0%), and larynx (level VI, 1/3, 33.3%).ConclusionLevels at greatest risk for nodal disease in cN0 in terms of ipsilateral neck dissection are level I (oral cavity), II (pharynx), and VI (larynx). These data should be considered when treating patients presenting with cN0. This is the first study to comprehensively report the incidence, location, and risk of metastases in cN0 in the FDG‐PET/CT era.
Association of Cortical and Subcortical β-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without Dementia
Syrjanen, Jeremy A. , Rakuša, Martin , Vemuri, Prashanthi , Kremers, Walter K. , Lowe, Val J. , Jack, Clifford R. , Stokin, Gorazd B. , Petersen, Ronald C. , Vassilaki, Maria , Geda, Yonas E. , Krell-Roesch, Janina, Jack, Clifford R , Vemuri, Prashanthi , Geda, Yonas E , Stokin, Gorazd , Kremers, Walter K , Krell‐Roesch, Janina , Machulda, Mary M. , Mielke, Michelle M. , Knopman, David S.

Mayo Clinic

The Journal of Neuropsychiatry and Clinical Neurosciences | October 22, 2020 | Volume: 33 | Issue: 1 | Pages: 64-71

10.1176/appi.neuropsych.20050103 | PMID 33086924 Get It

Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer’s Disease
Sintini, Irene , Graff‐Radford, Jonathan , Martin, Peter R. , Senjem, Matthew L. , Gunter, Jeffrey L. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Senjem, Matthew L , Jones, David T. , Botha, Hugo , Machulda, Mary M. , Schwarz, Christopher G. , Jack, Clifford R.

Mayo Clinic

Cerebral Cortex | October 6, 2020 | Volume: 31 | Issue: 3 | Pages: 1693-1706

10.1093/cercor/bhaa319 | PMID 33152765 Get It

AbstractThe mechanisms through which tau and amyloid-beta (Aβ) accumulate in the brain of Alzheimer’s disease patients may differ but both are related to neuronal networks. We examined such mechanisms on neuroimaging in 58 participants with atypical Alzheimer’s disease (posterior cortical atrophy or logopenic progressive aphasia). Participants underwent Aβ-PET, longitudinal tau-PET, structural MRI and resting-state functional MRI, which was analyzed with graph theory. Regions with high levels of Aβ were more likely to be functional hubs, with a high number of functional connections important for resilience to cascading network failures. Regions with high levels of tau were more likely to have low clustering coefficients and degrees, suggesting a lack of trophic support or vulnerability to local network failures. Regions strongly functionally connected to the disease epicenters were more likely to have higher levels of tau and, less strongly, of Aβ. The regional rate of tau accumulation was associated with tau levels in functionally connected regions, in support of tau accumulation in a functional network. This study elucidates the relations of tau and Aβ to functional connectivity metrics in atypical Alzheimer’s disease, strengthening the hypothesis that the spread of the 2 proteins is driven by different biological mechanisms related to functional networks.
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder
Hu, Michele T, Šonka, Karel , Miyamoto, Tomoyuki , Puligheddu, Monica , Tachibana, Naoko , Rolinski, Michal , Dušek, Petr , Lowe, Val J. , Miyamoto, Masayuki , Figorilli, Michela , Verbizier, Delphine de, Bossert, Irene , Meli, Riccardo, Barber, Thomas R. , Miyagawa, Toji , Serra, Alessandra , Bauckneht, Matteo , Bradley, Kevin M. , Zogala, David , McGowan, Daniel R. , Jordan, Lennon, Manni, Raffaele , Shulman, Joshua , Dušek, Petr , Miyamoto, Tomoyuki , Hu, Michele T M , Sonka, Karel , Figorilli, Michela , Puligheddu, Monica , Arnaldi, Dario , Chincarini, A. , Boeve, Bradley F. , Cochen De Cock, Valérie , Terzaghi, Michele , Plazzi, Giuseppe , Morbelli, Silvia , Antelmi, Elena , Trnka, Jiří , Pizza, Fabio , Nobili, Flavio Mariano

Mayo Clinic

Brain | September 30, 2020 | Volume: 144 | Issue: 1 | Pages: 278-287

10.1093/brain/awaa365 | PMID 33348363 Get It

Abstract This is an international multicentre study aimed at evaluating the combined value of dopaminergic neuroimaging and clinical features in predicting future phenoconversion of idiopathic REM sleep behaviour (iRBD) subjects to overt synucleinopathy. Nine centres sent 123I-FP-CIT-SPECT data of 344 iRBD patients and 256 controls for centralized analysis. 123I-FP-CIT-SPECT images were semiquantified using DaTQUANTTM, obtaining putamen and caudate specific to non-displaceable binding ratios (SBRs). The following clinical variables were also analysed: (i) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale, motor section score; (ii) Mini-Mental State Examination score; (iii) constipation; and (iv) hyposmia. Kaplan-Meier survival analysis was performed to estimate conversion risk. Hazard ratios for each variable were calculated with Cox regression. A generalized logistic regression model was applied to identify the best combination of risk factors. Bayesian classifier was used to identify the baseline features predicting phenoconversion to parkinsonism or dementia. After quality check of the data, 263 iRBD patients (67.6 ± 7.3 years, 229 males) and 243 control subjects (67.2 ± 10.1 years, 110 males) were analysed. Fifty-two (20%) patients developed a synucleinopathy after average follow-up of 2 years. The best combination of risk factors was putamen dopaminergic dysfunction of the most affected hemisphere on imaging, defined as the lower value between either putamina (P < 0.000001), constipation, (P < 0.000001) and age over 70 years (P = 0.0002). Combined features obtained from the generalized logistic regression achieved a hazard ratio of 5.71 (95% confidence interval 2.85–11.43). Bayesian classifier suggested that patients with higher Mini-Mental State Examination score and lower caudate SBR asymmetry were more likely to develop parkinsonism, while patients with the opposite pattern were more likely to develop dementia. This study shows that iRBD patients older than 70 with constipation and reduced nigro-putaminal dopaminergic function are at high risk of short-term phenoconversion to an overt synucleinopathy, providing an effective stratification approach for future neuroprotective trials. Moreover, we provide cut-off values for the significant predictors of phenoconversion to be used in single subjects.
Variants inPPP2R2BandIGF2BP3are associated with higher tau deposition
Ramanan, Vijay K. , Wang, Xuewei , Przybelski, Scott A. , Raghavan, Sheelakumari , Batzler, Anthony , Kosel, Matthew , Hohman, Timothy J. , Graff‐Radford, Jonathan , Lowe, Val J. , Petersen, Ronald C. , Ross, Owen A. , Vemuri, Prashanthi , Graff-Radford, Jonathan , Mielke, Michelle M , Seto, Mabel , Vemuri, Prashanthi , Ross, Owen A , Ramanan, Vijay K , Heckman, Michael G. , Knopman, David S. , Mielke, Michelle M. , Jack, Clifford R.

Mayo Clinic

Brain Communications | September 26, 2020 | Volume: 2 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcaa159 | PMID 33426524 Get It

AbstractTau deposition is a key biological feature of Alzheimer’s disease that is closely related to cognitive impairment. However, it remains poorly understood why certain individuals may be more susceptible to tau deposition while others are more resistant. The recent availability of in vivo assessment of tau burden through positron emission tomography provides an opportunity to test the hypothesis that common genetic variants may influence tau deposition. We performed a genome-wide association study of tau-positron emission tomography on a sample of 754 individuals over age 50 (mean age 72.4 years, 54.6% men, 87.6% cognitively unimpaired) from the population-based Mayo Clinic Study of Aging. Linear regression was performed to test nucleotide polymorphism associations with AV-1451 (18F-flortaucipir) tau-positron emission tomography burden in an Alzheimer’s-signature composite region of interest, using an additive genetic model and covarying for age, sex and genetic principal components. Genome-wide significant associations with higher tau were identified for rs76752255 (P = 9.91 × 10−9, β = 0.20) in the tau phosphorylation regulatory gene PPP2R2B (protein phosphatase 2 regulatory subunit B) and for rs117402302 (P = 4.00 × 10−8, β = 0.19) near IGF2BP3 (insulin-like growth factor 2 mRNA-binding protein 3). The PPP2R2B association remained genome-wide significant after additionally covarying for global amyloid burden and cerebrovascular disease risk, while the IGF2BP3 association was partially attenuated after accounting for amyloid load. In addition to these discoveries, three single nucleotide polymorphisms within MAPT (microtubule-associated protein tau) displayed nominal associations with tau-positron emission tomography burden, and the association of the APOE (apolipoprotein E) ɛ4 allele with tau-positron emission tomography was marginally nonsignificant (P = 0.06, β = 0.07). No associations with tau-positron emission tomography burden were identified for other single nucleotide polymorphisms associated with Alzheimer’s disease clinical diagnosis in prior large case–control studies. Our findings nominate PPP2R2B and IGF2BP3 as novel potential influences on tau pathology which warrant further functional characterization. Our data are also supportive of previous literature on the associations of MAPT genetic variation with tau, and more broadly supports the inference that tau accumulation may have a genetic architecture distinct from known Alzheimer’s susceptibility genes, which may have implications for improved risk stratification and therapeutic targeting.
Sensitivity–Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration
Ghirelli, Alma , Tosakulwong, Nirubol , Weigand, Stephen D. , Ali, Farwa , Buciuc, Marina , Murray, Melissa E. , Labuzan, Sydney A. , Spychalla, Anthony J., Pham, Nha Trang Thu, Senjem, Matthew L. , Rademakers, Rosa , Filippi, Massimo , Lowe, Val J. , Parisi, Joseph E., Josephs, Keith A. , Whitwell, Jennifer L. , Buciuc, Marina , Schwarz, Christopher G , Filippi, Massimo , Dickson, Dennis W , Josephs, Keith A , Whitwell, Jennifer , Senjem, Matthew L , Murray, Melissa E , Clark, Heather M. , Botha, Hugo , Duffy, Joseph R. , Utianski, Rene L. , Schwarz, Christopher G. , Machulda, Mary M. , Baker, Matthew , Jack, Clifford R. , Dickson, Dennis W.

Mayo Clinic

Annals of Neurology | September 1, 2020 | Volume: 88 | Issue: 5 | Pages: 1009-1022

10.1002/ana.25893 | PMID 32869362 Get It

ObjectiveTo examine associations between tau and amyloid β (Aβ) molecular positron emission tomography (PET) and both Alzheimer‐related pathology and 4‐repeat tau pathology in autopsy‐confirmed frontotemporal lobar degeneration (FTLD).MethodsTwenty‐four patients had [18F]‐flortaucipir–PET and died with FTLD (progressive supranuclear palsy [PSP], n = 10; corticobasal degeneration [CBD], n = 10; FTLD‐TDP, n = 3; and Pick disease, n = 1). All but 1 had Pittsburgh compound B (PiB)‐PET. Braak staging, Aβ plaque and neurofibrillary tangle counts, and semiquantitative tau lesion scores were performed. Flortaucipir standard uptake value ratios (SUVRs) were calculated in a temporal meta region of interest (meta‐ROI), entorhinal cortex and cortical/subcortical regions selected to match the tau lesion analysis. Global PiB SUVR was calculated. Autoradiography was performed in 1 PSP patient, with digital pathology used to quantify tau burden.ResultsNine cases (37.5%) had Aβ plaques. Global PiB SUVR correlated with Aβ plaque count, with 100% specificity and 50% sensitivity for diffuse plaques. Twenty‐one (87.5%) had Braak stages I to IV. Flortaucipir correlated with neurofibrillary tangle counts in entorhinal cortex, but entorhinal and meta‐ROI SUVRs were not elevated in Braak IV or primary age‐related tauopathy. Flortaucipir uptake patterns differed across FTLD pathologies and could separate PSP and CBD. Flortaucipir correlated with tau lesion score in red nucleus and midbrain tegmentum across patients, but not in cortical or basal ganglia regions. Autoradiography demonstrated minimal uptake of flortaucipir, although flortaucipir correlated with quantitative tau burden across regions.InterpretationMolecular PET shows expected correlations with Alzheimer‐related pathology but lacks sensitivity to detect mild Alzheimer pathology in FTLD. Regional flortaucipir uptake was able to separate CBD and PSP. ANN NEUROL 2020;88:1009–1022